我们的活动

  • Home
  • 我们的活动

Planova™我们的活动

Planova™Workshop为Planova用户提供了一个分享使用经验和学习病毒过滤最佳方法的机会。每年一度的盛会的主席和演讲嘉宾都是生物制药领域的行业领袖,他们的报告涵盖了诸如工艺优化技巧,验证,法规要求以及工艺放大的技巧。参会者包括监管机构,工艺开发,病原体安全性,质量和制造领域的专家。自1998年在挪威奥斯陆举行的第一届Planova™研讨会以来,这一年度盛会极大地促进了人们对病毒安全性的认识以及在生物制品生产过程中有效利用病毒过滤的意识。

Planova™地区研讨会是为满足某些特定地区需求而量身定制的研讨会,另外还包括来自全球和当地公司的案例研究以及针对该地区的病毒安全性最新法规的相关报告。

在此页面中,您可以浏览到最新活动的详细信息以及从以往的活动中下载您所需要的资料(需要登录)。
有关在线研讨会的更多信息,请访问地区研讨会页面。

最新活动

您可以在下面找到最新活动的详细信息,包括用于登记的表格。

2021 PLANOVA™ EU VIRTUAL SYMPOSIUM

以往的全球研讨会

在下面,您可以找到最近六届Planova™研讨会的详细信息,并下载报告材料(需要登录)。要查找更早的Planova™研讨会的信息,请单击存档。

以往的地区研讨会

在下面,您可以找到最近六届地区研讨会的详细信息,并下载报告材料(需要登录)。要查找更早的地区研讨会的信息,请单击存档。

查找报告

在这里,您可以通过输入关键字或过滤器类别来搜索和下载以往的Planova™研讨会的报告材料(需要登录)。

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to download the files.

155 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  1. Challenges of implementing virus filtration in continuous manufacturing

    Daniel Strauss, Ph.D., Principal Scientist Science and Technology
    Asahi Kasei Bioprocess America
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  2. Evaluating the Impact on Viral Clearance of Multiple Unplanned Interruptions During Virus Removal Filtration

    Kevin K. Okimura, Senior Manager Outsourced Manufacturing
    Portola Pharmaceuticals
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  3. Clearing the way for viral clearance

    David Cetlin, Founder/C.E.O.
    MockV Solutions
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  4. Of future biotechnology options and the central role of nanofiltrarion

    Andreas Wieser, D (I FH), Senior Laboratory Associate Global Pathogen Safety
    Shire
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  5. Meeting PlanovaTM and Selecting BioEX for Our Monoclonal Antibody Manufacturing Process

    Yumiko Masuda, Scientist Biologics Technology Research Laboratories Biologics Division
    Daiichi Sankyo
    Meeting Planova and Selecting BioEX for Our Monoclonal Antibody Manufacturing Process
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  6. Challenges & Strategies for Viral Filtration

    Matt (Mingjiang) Luo, Ph.D., Executive Director Downstream Process Development and Haikuan Liu, Ph.D., Associate Director Downstream Process Development
    Wuxi Biologics (Shanghai)
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  7. A Case Study: Evaluation of the Effect of Process Pause and Pressure Variation on Planova 20N Virus Filter

    Samuel Vollert, Process Development Scientist I Downstream Process Development
    Patheon (Thermo Fisher Scientific)
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  8. Clarification Impurities Impact Viral Filtration of a Therapeutic Antibody

    Ryan Zolyomi, Senior Development Associate Isolation & Purification Biological Development
    Bayer U.S.
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  9. Visualization of behavior of virus and proteins in Planova membrane filters using advanced microscope system with confocal optics

    Takayuki Nishizaka, Ph.D., Professor, Department of Physics
    Gakushuin University
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  10. Different apparent Size of Parvoviruses determined by Virus Filtration

    Thomas Nowak, Ph.D., Senior Manager Pathogen Safety
    CSL Behring
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  11. Establishing a Virus Filter Design Space - Impact of Process Interruption on Parvovirus Retention

    Ashlee Smith, Associate Scientist BioTherapeutics Development - API; Discovery, Product Development & Supply
    Janssen Research & Development
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  12. Overview of Challenges in Virus Filtration: Principles and Applications

    Tomoko Hongo-Hirasaki, Ph.D., Senior Scientist Evaluation and Analysis in Virus Filtration Bioprocess Division
    Asahi Kasei Medical
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  13. A Review of Virus Filter Performance

    Horst Ruppach, Ph.D., Director, Viral Clearance and Virology Biologics Testing Solutions
    Charles River Laboratories
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  14. Update on European Regulations

    Johannes Blümel, Ph.D., Head of Virus Safety Section Department of Virology
    Paul-Ehrlich-Institut
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  15. Consistent and Reliable 100% Retrovirus Removal by Planova™ 20N filter: Demonstration of Robust Log Reduction (>6.0) by Co-spiking Study

    Dayue Chen, Virology Group Bioprocess Research and Development, Eli Lilly and Company
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  16. Virus Inactivation at Low pH: Impact of Buffers, pH Value, Protein Concentration and Temperature on the Inactivation of Retroviruses

    Michael Dieterle, Associate Director Downstream Development, Boehringer Ingelheim GmbH&Co.KG
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  17. Implementation of Quality by Design to Nanofiltration of Plasma Products

    Monique Ollivier, Director, Process Development-Downstream & Analytics, Cytheris S.A.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  18. FULL PLASTICS for a 1000L Disposable Production Line for Generic Antibody Manufacturing

    Peter Rogge, Director, DSP Production, Rentschler Biotechnologie GmbH
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  19. New Concept of Integrity Test for Planova™ BioEX

    Shinya Sekine, Manager, Technology Development Department, Asahi Kasei Medical Co., Ltd.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  20. PDA Technical Report 41: Virus Filtration - History and the Future

    Kurt Brorson, Staff Scientist, CDER, FDA
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston